What is known. What is still being proved.

No universal suitability claim has been made. Skin history, known sensitivities, current treatment and individual response matter more than a broad label.

Final guidance will reflect the completed formula and its testing. Anyone managing a condition or prescribed treatment should ask a qualified professional.

Kesar Dew is being authored as one saffron-centered anointing gesture near the end of a skincare routine.

The development target is a lightweight, quick-settling face oil that conditions the skin without asking the product to become a correction campaign. Final sensory and performance language will follow finished-formula testing.

The intended position is near the end of a routine, after water-based products and, when used, moisturizer. Sunscreen remains the final protective step in the morning.

Final compatibility guidance will be published after the finished formula is tested with representative routine layers.

The final dose has not been published. It will be based on the finished dispenser, spread, settling time and wear testing rather than an attractive but unproven number.

Both are under consideration. Morning guidance depends on wear, transfer and sunscreen compatibility; evening guidance depends on the final texture and routine placement.

The working guidance is moisturizer first, then Kesar Dew. The product is a face oil, not a replacement for water-based hydration. Final instructions will reflect the completed formula.

The formula is being evaluated for enough controlled slip to support a gentle tool ritual without encouraging pressure or repeated dragging.

No sculpting, drainage or facial-transformation claim will be attached to that use.

A lightweight, quick-settling face-oil finish with restrained radiance rather than a wet or visibly glossy surface.

No. “Lightweight,” “quick-settling” and any final finish description remain development targets until the finished formula demonstrates them consistently.

The aromatic direction is restrained, warm and skin-close. The final scent profile, including whether added fragrance remains in the formula, will be published after formula lock and appropriate review.

The current study set includes saffron and a modern oil architecture being evaluated for stability, compatibility and sensory restraint. Botanical studies on this site describe the materials under consideration; they are not a final INCI list.

The formula may change as redundant, unstable or insufficiently useful materials are removed.

Publishing a provisional ingredient list would turn a development snapshot into a public promise. The complete INCI will be published when the formula is locked and the list is accurate.

Visible threads photograph beautifully but can introduce inconsistency, complicate dispensing and turn source material into theatre. Saffron belongs in the formula only in a controlled form that earns a functional role.

That has not been finalized. Anvaira will not use “fragrance-free,” “unscented” or related language until the final formula makes the statement accurate.

Not as a finished commercial formula. Testing status will be published plainly, including what was tested, on whom, for how long and what the result can reasonably support.

No non-staining promise has been made. The finished formula must pass the house skin and ivory-fabric transfer protocol before any transfer language is published.

Only when formula, packaging, landed costs and a credible release window can support the information. Anvaira will not use a countdown to make development feel more certain than it is.

Use Founder’s Release. It is a separate, one-message availability list and does not silently convert you into ongoing House Letters.